We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current DFFN market cap is 24.97M. The company's latest EPS is USD -0.3827 and P/E is -11.50.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 4.65M | 2.49M | 2.35M | 3.29M |
| Operating Income | -2.29M | 1.23M | -2.48M | -2.6M | -3M |
| Net Income | -2.11M | 6.4M | -2.36M | -2.51M | -2.32M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 7.15M |
| Operating Income | -11.55M | -15.98M | -24.68M | -15.97M | -7.81M |
| Net Income | -11.8M | -16.14M | -24.1M | -15.59M | -2.17M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 15.7M | 12.04M | 9.97M | 8M | 53.19M |
| Total Liabilities | 1.47M | 2.46M | 2.6M | 2.66M | 3.21M |
| Total Equity | 14.23M | 9.57M | 7.38M | 5.34M | 49.98M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 24.11M | 27.73M | 37.84M | 22.64M | 9.97M |
| Total Liabilities | 3.98M | 2.92M | 2.93M | 2.42M | 2.6M |
| Total Equity | 20.13M | 24.81M | 34.91M | 20.22M | 7.38M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -7.61M | -4.91M | -7.45M | -1.42M | -3.63M |
| Investing | 12.5M | N/A | N/A | N/A | -40.57M |
| Financing | N/A | 11.24M | 11.15M | N/A | 46.41M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -9.86M | -13.55M | -14.5M | -14.97M | -7.45M |
| Investing | N/A | N/A | 4k | -12.24M | N/A |
| Financing | 16.04M | 17.89M | 33.3M | 5k | 11.15M |
| Market Cap | 24.97M |
| Price to Earnings Ratio | -11.50 |
| Price to Sales Ratio | 3.49 |
| Price to Cash Ratio | 3.2 |
| Price to Book Ratio | 3.38 |
| Dividend Yield | - |
| Shares Outstanding | 5.68M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.02 (0.44%) |
| Company Name | Diffusion Pharmaceuticals Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.cervomed.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
